Quercetin nanocrystals for bioavailability enhancement: impact of different functional stabilizers on in vitro/in vivo drug performances

References

• Ahuja BK, Jena SK, Paidi SK, Bagri S, Suresh S. 2015. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension. Int J Pharm. 478(2):540–552.
   PubMed Web of Science ®Google Scholar
• Azeem M, Hanif M, Mahmood K, Ameer N, Chughtai FRS, Abid U. 2023. An insight into anticancer, antioxidant, antimicrobial, antidiabetic and anti-inflammatory effects of quercetin: a review. Polym Bull (Berl). 80(1):241–262.
   PubMed Web of Science ®Google Scholar
• Chen HJ, Li XF, Deng M, Xie L, Liu K, Zhang XM. 2022. Preparation and in vitro evaluation of quercetin nanosuspension stabilized by gypenosides. Zhongguo Zhong Yao Za Zhi. 47(16):4365–4371.
   PubMedGoogle Scholar
• Dhaval M, Makwana J, Sakariya E, Dudhat K. 2020. Drug nanocrystals: a comprehensive review with current regulatory guidelines. Curr Drug Deliv. 17(6):470–482. doi: 10.2174/1567201817666200512104833.
   PubMed Web of Science ®Google Scholar
• Fan M, Geng S, Liu Y, Wang J, Wang Y, Zhong J, Yan Z, Yu L. 2018. Nanocrystal technology as a strategy to improve drug bioavailability and antitumor efficacy for the cancer treatment. Curr Pharm Des. 24(21):2416–2424. doi: 10.2174/1381612824666180515154109.
   PubMed Web of Science ®Google Scholar
• Gao L, Liu G, Ma J, Wang X, Zhou L, Li X. 2012. Drug nanocrystals: in vivo performances. J Control Release. 160(3):418–430. doi: 10.1016/j.jconrel.2012.03.013.
   PubMed Web of Science ®Google Scholar
• Gao L, Liu G, Wang X, Liu F, Xu Y, Ma J. 2011. Preparation of a chemically stable quercetin formulation using nanosuspension technology. Int J Pharm. 404(1-2):231–237.
   PubMed Web of Science ®Google Scholar
• Ge ZQ, Du XY, Huang XN, Qiao B. 2015. Enhanced oral bioavailability of ursolic acid nanoparticles via antisolvent precipitation with TPGS1000 as a stabilizer. J Drug Deliv Sci Tec. 29:210–217.
   Web of Science ®Google Scholar
• Geng T, Banerjee P, Lu Z, Zoghbi A, Li T, Wang B. 2017. Comparative study on stabilizing ability of food protein, non-ionic surfactant and anionic surfactant on BCS type II drug carvedilol loaded nanosuspension: physicochemical and pharmacokinetic investigation. Eur J Pharm Sci. 109:200–208.
   PubMed Web of Science ®Google Scholar
• Gigliobianco MR, Casadidio C, Censi R, Di Martino P. 2018 Aug 21. Nanocrystals of poorly soluble drugs: drug bioavailability and physicochemical stability. Pharmaceutics. 10(3):134. doi: 10.3390/pharmaceutics10030134.
   PubMed Web of Science ®Google Scholar
• Hang L, Hu F, Shen C, Shen B, Zhu W, Yuan H. 2021. Development of herpetrione nanosuspensions stabilized by glycyrrhizin for enhancing bioavailability and synergistic hepatoprotective effect. Drug Dev Ind Pharm. 47(10):1664–1673. doi: 10.1080/03639045.2022.2045304.
   PubMed Web of Science ®Google Scholar
• He W, Lu Y, Qi J, Chen L, Hu F, Wu W. 2013. Food proteins as novel nanosuspension stabilizers for poorly water-soluble drugs. Int J Pharm. 441(1-2):269–278. doi: 10.1016/j.ijpharm.2012.11.033.
   PubMed Web of Science ®Google Scholar
• Hu F, Che ZH, Wang Z, Li FQ, Yan Q, Shen CY, Shen BD, Yuan HL. 2022. Pharmacokinetics and tissue distribution of quercetin nanocrystals modified with different stabilizers following intravenous delivery in rats. Zhong Cao Yao. 53(9):2697–2705.
   Google Scholar
• Hu F, Shen CY, Shen BD, Zhu WF, Yuan HL. 2021. Effect of different stabilizers on in vitro dissolution and oral pharmacokinetics of quercetin nanocrystals in rats. Zhong Cao Yao. 52(21):6485–6492.
   Google Scholar
• Jin X, Luo Y, Chen Y, Ma Y, Yue P, Yang M. 2019. Novel breviscapine nanocrystals modified by panax notoginseng saponins for enhancing bioavailability and synergistic anti-platelet aggregation effect. Colloids Surf B Biointerfaces. 175:333–342.
   PubMed Web of Science ®Google Scholar
• Junyaprasert VB, Morakul B. 2015. Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs. Asian J Pharm Sci. 10(1):13–23.
   Web of Science ®Google Scholar
• Kang SG, Lee GB, Vinayagam R, Do GS, Oh SY, Yang SJ, Kwon JB, Singh M. 2022. Anti-inflammatory, antioxidative, and nitric oxide-scavenging activities of a quercetin nanosuspension with polyethylene glycol in LPS-induced RAW 264.7 macrophages. Molecules. 27(21):7432. doi: 10.3390/molecules27217432.
   PubMed Web of Science ®Google Scholar
• Keck CM, Müller RH. 2006. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm. 62(1):3–16. doi: 10.1016/j.ejpb.2005.05.009.
   PubMed Web of Science ®Google Scholar
• Li H, Li M, Fu J, Ao H, Wang W, Wang X. 2021. Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions. Drug Deliv. 28(1):1226–1236.
   PubMed Web of Science ®Google Scholar
• Li J, Wang Z, Zhang H, Gao J, Zheng A. 2021. Progress in the development of stabilization strategies for nanocrystal preparations. Drug Deliv. 28(1):19–36.
   PubMed Web of Science ®Google Scholar
• Liu Q, Guan J, Sun Z, Shen X, Li L, Jin L, Mao S. 2019. Influence of stabilizer type and concentration on the lung deposition and retention of resveratrol nanosuspension-in-microparticles. Int J Pharm. 569:118562.
   PubMed Web of Science ®Google Scholar
• Liu Q, Yang X, Sun J, Yu F, Zhang H, Gao J, Zheng A. 2019. Size-dependent biological effects of quercetin nanocrystals. Molecules. 24(7):1438. doi: 10.3390/molecules24071438.
   PubMed Web of Science ®Google Scholar
• Liu X, Liu J, Pang JY, Shen BD, Shen CY, Lian WQ, Li XF, Yuan HL. 2017. Preparation of nanosuspension of quercetin with a miniaturized milling method. Zhongguo Zhong Yao Za Zhi. 42(15):2984–2988.
   PubMedGoogle Scholar
• Long J, Song J, Zhang X, Deng M, Xie L, Zhang L, Li X. 2020. Tea saponins as natural stabilizers for the production of hesperidin nanosuspensions. Int J Pharm. 583:119406. doi: 10.1016/j.ijpharm.2020.119406.
   PubMedGoogle Scholar
• Lu L, Xu Q, Wang J, Wu S, Luo Z, Lu W. 2022. Drug Nanocrystals for Active Tumor-Targeted Drug Delivery. Pharmaceutics. 14(4):797. doi: 10.3390/pharmaceutics14040797.
   PubMed Web of Science ®Google Scholar
• McGuckin MB, Wang J, Ghanma R, Qin N, Palma SD, Donnelly RF, Paredes AJ. 2022. Nanocrystals as a master key to deliver hydrophobic drugs via multiple administration routes. J Control Release. 345:334–353.
   PubMed Web of Science ®Google Scholar
• Mohammad IS, Hu H, Yin L, He W. 2019. Drug nanocrystals: fabrication methods and promising therapeutic applications. Int J Pharm. 562:187–202.
   PubMedGoogle Scholar
• Pardhi VP, Verma T, Flora SJS, Chandasana H, Shukla R. 2018. Nanocrystals: an overview of fabrication, characterization and therapeutic applications in drug delivery. Curr Pharm Des. 24(43):5129–5146. doi: 10.2174/1381612825666190215121148.
   PubMed Web of Science ®Google Scholar
• Qiao Y, Cao Y, Yu K, Zong L, Pu X. 2020. Preparation and antitumor evaluation of quercetin nanosuspensions with synergistic efficacy and regulating immunity. Int J Pharm. 589:119830.
   PubMedGoogle Scholar
• Rahim H, Sadiq A, Ullah R, Bari A, Amin F, Farooq U, Ullah Jan N, Mahmood HM. 2020. Formulation of aceclofenac tablets using nanosuspension as granulating agent: an attempt to enhance dissolution rate and oral bioavailability. Int J Nanomedicine. 15:8999–9009. doi: 10.2147/IJN.S270746.
   PubMed Web of Science ®Google Scholar
• Selyutina OY, Polyakov NE. 2019. Glycyrrhizic acid as a multifunctional drug carrier - From physicochemical properties to biomedical applications: a modern insight on the ancient drug. Int J Pharm. 559:271–279. doi: 10.1016/j.ijpharm.2019.01.047.
   PubMed Web of Science ®Google Scholar
• Sharma S, Verma A, Pandey G, Mittapelly N, Mishra PR. 2015. Investigating the role of Pluronic-g-Cationic polyelectrolyte as functional stabilizer for nanocrystals: impact on Paclitaxel oral bioavailability and tumor growth. Acta Biomater. 26:169–183. doi: 10.1016/j.actbio.2015.08.005.
   PubMed Web of Science ®Google Scholar
• Shen B, Shen C, Zhu W, Yuan H. 2021. The contribution of absorption of integral nanocrystals to enhancement of oral bioavailability of quercetin. Acta Pharm Sin B. 11(4):978–988.
   PubMed Web of Science ®Google Scholar
• Shen B, Wu N, Shen C, Zhang F, Wu Y, Xu P, Zhang L, Wu W, Lu Y, Han J, et al. 2016. Hyperoside nanocrystals for HBV treatment: process optimization, in vitro and in vivo evaluation. Drug Dev Ind Pharm. 42(11):1772–1781.
   PubMed Web of Science ®Google Scholar
• Shen C, Yang Y, Shen B, Xie Y, Qi J, Dong X, Zhao W, Zhu W, Wu W, Yuan H, et al. 2018. Self-discriminating fluorescent hybrid nanocrystals: efficient and accurate tracking of translocation via oral delivery. Nanoscale. 10(1):436–450. doi: 10.1039/c7nr06052a.
   Web of Science ®Google Scholar
• Shen C, Zhu J, Song J, Wang J, Shen B, Yuan H, Li X. 2020. Formulation of pluronic F127/TPGS mixed micelles to improve the oral absorption of glycyrrhizic acid. Drug Dev Ind Pharm. 46(7):1100–1107.
   PubMed Web of Science ®Google Scholar
• Soisuwan S, Teeranachaideekul V, Wongrakpanich A, Langguth P, Junyaprasert VB. 2019 Apr. Impact of uncharged and charged stabilizers on in vitro drug performances of clarithromycin nanocrystals. Eur J Pharm Biopharm. 137:68–76.
   PubMed Web of Science ®Google Scholar
• Tian Y, Wang S, Yu Y, Sun W, Fan R, Shi J, Gu W, Wang Z, Zhang H, Zheng A, et al. 2022 Jul 25. Review of nanosuspension formulation and process analysis in wet media milling using microhydrodynamic model and emerging characterization methods. Int J Pharm. 623:121862. doi: 10.1016/j.ijpharm.2022.121862.
   PubMedGoogle Scholar
• Tuomela A, Hirvonen J, Peltonen L. 2016. Stabilizing agents for drug nanocrystals: effect on bioavailability. Pharmaceutics. 8(2):16. doi: 10.3390/pharmaceutics8020016.
   PubMed Web of Science ®Google Scholar
• Ueda K, Iwai T, Sunazuka Y, Chen Z, Kato N, Higashi K, Moribe K. 2019 Jun 10. Effect of molecular weight of hypromellose on mucin diffusion and oral absorption behavior of fenofibrate nanocrystal. Int J Pharm. 564:39–47.
   PubMed Web of Science ®Google Scholar
• Wang XH, Liu Y, Shen CY, Shen BD, Zhong RN, Yuan HL. 2019. Effect of particle size on in vitro and in vivo behavior of astilbin nanosuspensions. J Drug Deliv Sci Tec. 52:778–783.
   Web of Science ®Google Scholar
• Wang Z, Dai B, Tang X, Che Z, Hu F, Shen C, Wu W, Shen B, Yuan H. 2022. Fabrication and In Vitro/Vivo Evaluation of Drug Nanocrystals Self-Stabilized Pickering Emulsion for Oral Delivery of Quercetin. Pharmaceutics. 14(5):897. doi: 10.3390/pharmaceutics14050897.
   PubMed Web of Science ®Google Scholar
• Yang H, Kim H, Jung S, Seo H, Nida SK, Yoo SY, Lee J. 2018. Pharmaceutical Strategies for Stabilizing Drug Nanocrystals. Curr Pharm Des. 24(21):2362–2374. doi: 10.2174/1381612824666180515125247.
   PubMed Web of Science ®Google Scholar
• Yue PF, Li Y, Wan J, Wang Y, Yang M, Zhu WF, Wang CH, Yuan HL. 2013. Process optimization and evaluation of novel baicalin solid nanocrystals. Int J Nanomedicine. 8:2961–2973. doi: 10.2147/IJN.S44924.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li L, Gao X, Zhang H, Gao J, Du Y, Huang X, Zheng A. 2020. In vitro evaluation of quercetin nanocrystals with different particle sizes. J Nanosci Nanotechnol. 20(10):6469–6474. doi: 10.1166/jnn.2020.18580.
   PubMed Web of Science ®Google Scholar
• Zhao J, Liu Y, Wang L, Zhou Y, Du J, Wang Y. 2018. Functional and modified nanocrystals technology for target drug delivery. J Nanosci Nanotechnol. 18(8):5207–5221. doi: 10.1166/jnn.2018.15421.
   PubMed Web of Science ®Google Scholar
• Zou H, Ye H, Kamaraj R, Zhang T, Zhang J, Pavek P. 2021. A review on pharmacological activities and synergistic effect of quercetin with small molecule agents. Phytomedicine. 92:153736. doi: 10.1016/j.phymed.2021.153736.
   PubMed Web of Science ®Google Scholar